The people

What they build
Open roles via the TechTO Job Board
Working at Eve Medical
Browse open roles across the community on the TechTO Job Board — Canada’s most connected tech network. Eve Medical’s roles show up here whenever they post.
Open roles on the TechTO Job Board ↗Or their own careers page: eve-medical.com/careers ↗Jobs live on jobs.techto.org — the only structured source. We link to it rather than scraping career sites, so the board is always the source of truth.
On the TechTO stage
Every talk is searchable — ask the archive about Eve Medical ↗
About
Eve Medical is a Toronto medtech company founded in 2010 by Jessica Ching and Evan Moses. Its product, HerSwab, is a hand-held self-sampling device that lets a woman collect her own sample for HPV, cervical cancer and STI testing — at home or in a clinic — instead of a clinician-performed speculum exam. Ching, an industrial designer trained at OCAD University, started the company after a conversation with friends about how routinely women put the test off; research on self-sampling showed it raised participation, but the devices being handed to patients had been designed for clinicians rather than for the people using them. Eve Medical designed for the patient instead. The company has Health Canada approval, and its device has been used by health authorities for in-clinic self-sampling internationally.
Backers
Eve Medical's investors were not confirmed in the sources checked. It has worked through Toronto health-innovation programs including Sunnybrook's Medventions and OBIO.
Quick answers
What does Eve Medical do?
It makes HerSwab, a self-sampling device for cervical cancer and STI screening. A woman collects her own sample rather than undergoing a clinician-performed exam, which removes several of the reasons screening gets skipped.
Who founded Eve Medical?
Jessica Ching and Evan Moses, in Toronto in 2010. Ching, an OCAD-trained industrial designer, is CEO and leads product; Moses handles operations and finance.
Why was HerSwab designed?
Self-sampling was already shown to raise screening participation, but the devices patients were given had been designed for clinical use. Ching told TechTO in 2017 that this caused usability, consistency and confidence problems, so Eve Medical designed one for the patient.